the main difference between the two cooperative studies on therapy of childhood acute myelogenous leukemia aml-bfm-78 and aml-bfm-83 was the addition of an 8-day ade ( cytosine arabinoside , daunorubicin , etoposide ) induction treatment in the second study .
C0057163
ade
C0010711
cytosine arabinoside